France· FR:68138844
AMPHOTERICINE B LIPOSOMAL MEDIPHA 50 mg, poudre pour dispersion à diluer pour dispersion pour perfusion
A medicinal product containing amphotéricine b liposomale, registered in France by MEDIPHA SANTE.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- AMPHOTÉRICINE B LIPOSOMALE
- Manufacturer
- MEDIPHA SANTE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095511071210 flacons en verre de 20 ml avec filtres
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Amphotéricine b liposomale in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsAmfotericine B liposomaal Tillomed 50 mg poeder voor concentraat voor dispersie voor infusieTillomed Malta Limited
- United KingdomAbelcet 100mg/20ml concentrate for dispersion for infusion vialsTeva UK Ltd
- FinlandAbelcetTeva Pharma B.V.
- SwitzerlandAmbisome
- United StatesAmBisomeAstellas Pharma US, Inc.
- CzechiaABELCET LIPID COMPLEXTeva Pharmaceuticals CR, s.r.o., Praha
- PolandAbelcetTeva Pharmaceuticals Polska Sp. z o.o.
- GermanyAmbisome LiposomalGilead Sciences Gmbh
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Ambisome Liposomal, Ampho-Moronal
- Belgium · Ambisome Liposomales, Amfotericine B Liposomaal Tillomed
- Bulgaria · Амфотерицин B Липозомал Тиломед
- Cyprus · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Czechia · Abelcet Lipid Complex, Amfotericin B Liposomal Tillomed
- Germany · Ambisome Liposomal, Ampho-Moronal
- Denmark · Ambisome Liposomal
- Estonia · Amphotericin B Liposomal Tillomed
- Spain · Abelcet Complejo Lipídico, Ambisome Liposomal
- Finland · Ambisome Liposomal, Fungizone
- United Kingdom (Northern Ireland) · Amphotericin B Liposomal Gilead, Amphotericin B Liposomal Sun Pharma
- Greece · Ambisome Liposomal
- Hungary · Abelcet, Ambisome Liposzómás
- Ireland · Ambisome liposomal, Amphotericin B Liposomal Tillomed
- Iceland · Ambisome Liposomal
- Italy · Ambisome Liposomiale, Fungizone
- Luxembourg · Abelcet Lipid Complex, Ambisome Liposomales
- Latvia · Ambisome liposomāls, Amphotericin B Tillomed
- Malta · Ambisome Liposomal
- Netherlands · Ambisome liposomale, Amfotericine B Liposomaal Tillomed
- Norway · Ambisome Liposomal
- Poland · Abelcet, Ambisome Liposomal
- Portugal · Abelcet, Ambisome Lipossomal
- Romania · Ambisome liposomal, Amfotericină B Lipozomală Tillomed
- Sweden · Ambisome Liposomal, Amphotericin B Liposomal Tillomed
- Slovenia · Ambisome Liposomal, Amfotericin B Liposomal Tillomed
- Slovakia · Abelcet Lipid Complex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/19f8f4fb-c675-464b-80ca-72f313c0a013 GET /v1/drugs/19f8f4fb-c675-464b-80ca-72f313c0a013?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68138844",
"date_amm": "2025-09-09",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "AMPHOTÉRICINE B LIPOSOMALE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre pour dispersion à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about amphotéricine b liposomale.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.